Aaron Brinkworth
Förmögenhet: 12 692 $ per 2026-09-30
Förmögenhet: 12 692 $ per 2026-09-30
Mr. Aaron Brinkworth is an Independent Non-Executive Director at Proteomics International Laboratories Ltd. and a Chairman at Resonance Health Ltd. He is on the Board of Directors at Proteomics International Laboratories Ltd. and Lixa Pty Ltd. Mr. Brinkworth was previously employed as an Executive Director-Global Patient Solutions by Gilead Sciences, Inc. He received his undergraduate degree from the University of Edith Cowan.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-06-30 | 135 135 ( 0,08 % ) | 12 692 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| RESONANCE HEALTH LIMITED | Ordförande | 2025-11-13 |
| PROTEOMICS INTERNATIONAL LABORATORIES LTD | Direktör/Styrelseledamot | 2024-11-08 |
Lixa Pty Ltd.
Lixa Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antimicrobial resistance | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| GILEAD SCIENCES, INC. | Företagsledare/Principal | 2020-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Resonance Health Ltd.
Resonance Health Ltd. Medical/Nursing ServicesHealth Services Operates as a healthcare company, which involves in the development and commercialization of technologies & services for radiological images | Health Services |
University of Edith Cowan
University of Edith Cowan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd. Medical/Nursing ServicesHealth Services Provides biological research and drug discovery services | Health Services |
Lixa Pty Ltd.
Lixa Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antimicrobial resistance | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån